166 related articles for article (PubMed ID: 14888460)
1. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
BARKER NW; HANSON HH; MANN FD
J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
[No Abstract] [Full Text] [Related]
2. Comparison of the anticoagulant action of 3-(alpha-p-chlorphenyl-beta-acetylethyl)-4-hydroxycoumarin (coumachlor) and dicoumarol in chicks and rats.
DAM H; SØNDERGAARD E
Acta Pharmacol Toxicol (Copenh); 1953; 9(2):137-47. PubMed ID: 13079850
[No Abstract] [Full Text] [Related]
3. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
SCARRONE LA; BECK DF; WRIGHT IS
Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
[No Abstract] [Full Text] [Related]
4. [PAPER CHROMATOGRAPHIC DEMONSTRATION OF THE ANTICOAGULANTS 3-(1-PHENYLPROPYL)-4-HYDROXYCOUMARIN (FALITHROM) AND THE ETHYL ESTER OF DIHYDROXYCOUMARINYLACETIC ACID (PELENTAN)].
FROST E; SEIDLEIN HJ
Pharm Prax; 1964; 204():28-33. PubMed ID: 14235737
[No Abstract] [Full Text] [Related]
5. [SKIN NECROSES IN ANTICOAGULANT THERAPY].
STACHER A
Wien Z Inn Med; 1964 Feb; 45():47-9. PubMed ID: 14155957
[No Abstract] [Full Text] [Related]
6. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
SCHIAVINA GP
Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
[No Abstract] [Full Text] [Related]
7. An effect of drugs derived from 4-hydroxycoumarins not depending on hypoprothrombinaemia.
DERECHIN M
Arch Int Pharmacodyn Ther; 1957 Aug; 111(3):362-5. PubMed ID: 13459521
[No Abstract] [Full Text] [Related]
8. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
PUNDEL JP
Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
[No Abstract] [Full Text] [Related]
9. PETECHIAE, ECCHYMOSES, AND NECROSIS OF SKIN INDUCED BY COUMARIN CONGENERS: RARE, OCCASIONALLY LETHAL COMPLICATION OF ANTICOAGULANT THERAPY.
NALBANDIAN RM; MADER IJ; BARRETT JL; PEARCE JF; RUPP EC
JAMA; 1965 May; 192():603-8. PubMed ID: 14284863
[No Abstract] [Full Text] [Related]
10. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].
LEROUX M; JAMAIN B
Therapie; 1956; 11(1):85-101. PubMed ID: 13337762
[No Abstract] [Full Text] [Related]
11. The anticoagulant action of some derivatives of 3,3'-(arylidene)-bis-4-hydroxycoumarin.
GUMINSKA M; ECKSTEIN M
J Med Pharm Chem; 1961 May; 3():583-95. PubMed ID: 13902930
[No Abstract] [Full Text] [Related]
12. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
TOOHEY M
Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
[No Abstract] [Full Text] [Related]
13. Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate.
CHATTERJEA JB; SALOMON L
Br Med J; 1954 Oct; 2(4891):790-2. PubMed ID: 13199310
[No Abstract] [Full Text] [Related]
14. The effect of coumarin drugs upon plasma thromboplastin component.
MCELFRESH AE; OZGE A
J Lab Clin Med; 1957 May; 49(5):753-5. PubMed ID: 13416734
[No Abstract] [Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria: report of four cases, with observations on treatment with 3, 3'-methylenebis (4-hydroxycoumarin) (dicumarol).
PERKINS HA; BOULWARE JM; FEICHTMEIR TV; THAYER WW; SPAET TH
Ann Intern Med; 1955 Dec; 43(6):1218-29. PubMed ID: 13269013
[No Abstract] [Full Text] [Related]
16. [Derivative of 4-hydroxycoumarin as a new anticoagulant].
KLOSA J
Pharmazie; 1954 Aug; 9(8):622. PubMed ID: 13224346
[No Abstract] [Full Text] [Related]
17. [The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
DELLA SANTA R
Helv Med Acta Suppl; 1952; 19(28):1-64. PubMed ID: 13044126
[No Abstract] [Full Text] [Related]
18. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
KNOBEL P
Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
[No Abstract] [Full Text] [Related]
19. [MODIFICATION OF ANTICOAGULANT THERAPY BY A DIURETIC].
VINAZZER H
Wien Z Inn Med; 1963 Jul; 44():323-7. PubMed ID: 14048088
[No Abstract] [Full Text] [Related]
20. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
